Login
From:
OncLive
(Uncensored)
subscribe
Dr Heldermon on a Phase 1/2 Trial Design of Epidiferphane Plus a Taxane in Breast Cancer
https://www.onclive.com/view/dr-heldermon-on-a-phase-1-2-trial-design-of-epidiferphane-plus-a-taxane-in-breast-cancer
links
backlinks
Tagged with:
breast cancer
cancer research news
coy heldermon
onclive
Coy Heldermon, MD, PhD, discusses a phase 1/2 trial design evaluating pharmacokinetics and safety of epidiferphane given with taxane chemotherapy in breast cancer.
Roast topics
Find topics
Find it!
